What’s Hot in Seattle Biotech→
June 21st, 2015
Bluebird Bio (NASDAQ: BLUE) hired former Sangamo Biosciences (NASDAQ: SGMO) chief scientific officer and research chief Phillip Gregory as its new CSO.
Ben Fidler is Xconomy's Deputy Biotechnology Editor. You can e-mail him at firstname.lastname@example.org Follow @benthefidler
From Our Editors · Video
Lita Nelsen recently retired as the long-time director of MIT’s Technology Licensing Office.
Xconomy Insight · Special Report
Success or failure depends on you. Get advice from the experts to help your startup succeed
Video interview with David Berry, general partner at Flagship Pioneering.
Providence Ventures seeks innovative approaches to care delivery
The Hidden Risks of Sourcing Human Biological Samples
More than $2 billion available annually
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2018, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.